FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to immunoeffectors of formula:
,
where n equals 1 (C6alkyl) or 5 (C10 alkyl), and R1 represents CO2H.
EFFECT: claimed novel compounds and pharmaceutical compositions based on them enhance immune response, increase production of antibodies in immunised animals, stimulate production of cytokines and activate macrophages.
7 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPAHTE DERIVATIVES AND USE THEREOF | 2004 |
|
RU2389732C2 |
| COMPOSITIONS OF RECOMBINANT CDV AND ITS USE | 2011 |
|
RU2567337C2 |
| RECOMBINANT VACCINE AGAINST AVIAN FLU AND APPLICATION THEREOF | 2009 |
|
RU2559527C2 |
| MULTI-COMPONENT IMMUNOGENIC COMPOSITION FOR PREVENTING DOSEASE, CAUSED BY β-HEMOLYTIC STREPTOCCOCI (BHS) | 2009 |
|
RU2478396C2 |
| TREATMENT AND PREVENTION OF NEURODGENERATIVE DISEASES WITH USE OF GENE THERAPY | 2008 |
|
RU2471487C2 |
| FMDV VACCINES BASED ON A RECOMBINANT ADENOVIRAL VECTOR AND USE THEREOF | 2017 |
|
RU2725495C2 |
| FMDV-E2 FUSION PROTEINS AND USE THEREOF | 2016 |
|
RU2714428C2 |
| RECOMBINANT BLUETONGUE VACCINE | 2007 |
|
RU2446823C2 |
| DNA PLASMIDS SHOWING HIGH EXPRESSION AND STABILITY | 2007 |
|
RU2456346C2 |
| IMMUNOGENIC COMPOSITION APPLICABLE FOR STAPHYLOCOCCUS VACCINATION | 2009 |
|
RU2521501C2 |
